Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLNO
176
DELISTED
Soleno Therapeutics
SLNO
| $233M | 0.12% |
5,188,265
+1,107,166
| +27% | +$57.4M |
|
177
American Electric Power
AEP
$72.7B
| $232M | 0.12% |
2,513,856
-1,239,394
| -33% | -$120M |
|
178
Novartis
NVS
$297B
| $230M | 0.12% |
2,358,523
-183,338
| -7% | -$19.6M |
|
179
Palo Alto Networks
PANW
$259B
| $228M | 0.12% |
1,255,102
+139,552
| +13% | +$26.4M |
|
180
Booz Allen Hamilton
BAH
$8.59B
| $227M | 0.12% |
1,767,129
+1,135,426
| +180% | +$176M |
|
|
181
Honeywell
HON
$77.9B
| $226M | 0.12% |
1,062,375
-3,159,208
| -75% | -$659M |
|
182
Micron Technology
MU
$1.02T
| $223M | 0.11% |
2,646,936
+1,130,680
| +75% | +$115M |
|
183
Royal Caribbean
RCL
$81.8B
| $222M | 0.11% |
963,034
+936,609
| +3,544% | +$207M |
|
184
Analog Devices
ADI
$181B
| $221M | 0.11% |
1,041,502
-702,046
| -40% | -$155M |
|
185
Cimpress
CMPR
$2.41B
| $218M | 0.11% |
3,041,361
+194,034
| +7% | +$15.2M |
|
186
Blackbaud
BLKB
$1.59B
| $213M | 0.11% |
2,885,062
+34,600
| +1% | +$2.83M |
|
187
Adobe
ADBE
$94.5B
| $210M | 0.11% |
471,407
-233,090
| -33% | -$115M |
|
188
Wayfair
W
$12.5B
| $209M | 0.11% |
4,709,301
+1,017,839
| +28% | +$48M |
|
189
OSI Systems
OSIS
$3.58B
| $206M | 0.1% |
1,230,805
+21,637
| +2% | +$3.43M |
|
|
RNAM
190
DELISTED
Avidity Biosciences
RNAM
| $205M | 0.1% |
7,053,010
+2,156,844
| +44% | +$90.1M |
|
191
Moody's
MCO
$84.2B
| $202M | 0.1% |
427,425
+124,012
| +41% | +$59.2M |
|
192
Procore
PCOR
$7.03B
| $197M | 0.1% |
2,627,408
+322,367
| +14% | +$22.9M |
|
193
Western Alliance Bancorporation
WAL
$9.04B
| $196M | 0.1% |
2,341,553
+445,176
| +23% | +$39.2M |
|
194
Vertiv
VRT
$110B
| $195M | 0.1% |
1,716,724
-1,293,223
| -43% | -$154M |
|
195
Apollo Global Management
APO
$71.6B
| $193M | 0.1% |
1,168,613
-170,742
| -13% | -$27M |
|
196
Texas Instruments
TXN
$255B
| $192M | 0.1% |
1,024,895
-1,851,192
| -64% | -$370M |
|
|
JEMB
197
Janus Henderson Emerging Markets Debt Hard Currency ETF
JEMB
$436M
| $191M | 0.1% |
3,829,035
-540,130
| -12% | -$27.6M |
|
198
Janux Therapeutics
JANX
$950M
| $191M | 0.1% |
3,562,402
+1,038,996
| +41% | +$55M |
|
199
Ziff Davis
ZD
$1.93B
| $190M | 0.1% |
3,487,495
+272,895
| +8% | +$14.3M |
|
200
Mirum Pharmaceuticals
MIRM
$6.96B
| $189M | 0.1% |
4,581,642
+101,358
| +2% | +$4.22M |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.